News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Missouri
Pharmacy benefit managers
Cigna to Remove AbbVie’s Humira From Formularies, Putting More Pressure on Blockbuster
Mirroring fellow pharmacy benefit manager CVS Caremark, Cigna’s Express Scripts is taking Humira off its major commercial formularies starting next year and focusing on more affordable biosimilar options.
August 27, 2024
·
2 min read
·
Tristan Manalac
PRESS RELEASES
Press Releases
Wugen Announces Dosing of First Patients in Pivotal Trial of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007
March 20, 2025
·
4 min read
Press Releases
Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program
March 19, 2025
·
3 min read
Press Releases
Samsung Invests in C2N Diagnostics
March 13, 2025
·
4 min read
Press Releases
Stereotaxis to Present at 37th Annual Roth Conference
March 10, 2025
·
1 min read
Press Releases
CENTENE TO PRESENT AT BARCLAYS 27TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
March 7, 2025
·
1 min read
Press Releases
Cofactor Genomics Announces the Expansion of OncoPrism into Colorectal, Breast, Bladder, and Kidney Cancer
March 6, 2025
·
3 min read
Press Releases
Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN®
March 5, 2025
·
6 min read
Press Releases
Geneoscopy’s Dr. Erica Barnell to Speak at ACG’s ‘Leading With Guts’ Course on Expanding Career Opportunities in Gastroenterology
March 4, 2025
·
2 min read
Press Releases
Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery
March 4, 2025
·
4 min read
Press Releases
Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance
March 4, 2025
·
4 min read
Press Releases
Wugen Announces Appointment of Jim Faulkner, Ph.D., as Chief Technology Officer
February 27, 2025
·
3 min read
Press Releases
Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference
February 26, 2025
·
1 min read
Press Releases
MediBeacon® Transdermal GFR System receives device approval in China
February 26, 2025
·
8 min read
Press Releases
MediBeacon® Transdermal GFR System receives device approval in China; Peer-reviewed articles on MediBeacon technology published
February 26, 2025
·
8 min read
Press Releases
Panome Bio Welcomes Jean-Pierre Wery to Its Board of Directors as it Prepares for Growth in 2025
February 25, 2025
·
2 min read
Press Releases
C2N Diagnostics’ PrecivityAD2™ Blood Test Receives MHRA Medical Device Certification in the United Kingdom
February 25, 2025
·
4 min read
Press Releases
U.S. Patent Trial and Appeal Board Institutes Inter Partes Review Based on Geneoscopy’s Petition Challenging Validity of a Second Patent Asserted by Exact Sciences
February 18, 2025
·
2 min read
Press Releases
Particle Dynamics Appoints New Vice President of Sales and Marketing as it Sets Sights on Market Expansion and Rapid Growth
February 17, 2025
·
3 min read
Press Releases
ASL Strategic Value Fund Letter to Avadel Pharmaceuticals (AVDL: NASDAQ) Board of Directors
February 10, 2025
·
4 min read
Press Releases
Leinco Technologies Awarded $1M Grant to Develop Rapid Test for Intestinal Immunity to Polio
February 6, 2025
·
2 min read